Author:
O’Hara Julia A.,Blumenthal Rosalyn D.,Grinberg Oleg Y.,Grinberg Stalina,Wilmot Carmen,Goldenberg David M.,Swartz Harold M.
Reference22 articles.
1. Sharkey RM, Pykett MJ, Siegel JA, Alger EA, Primus FJ, Goldenberg DM. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Cancer Res 1987;47:5672–5677.
2. Ceriani RL, Blank EW. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule [published erratum appears in Cancer Res 1989 Sep 15;49:5236]. Cancer Res 1988;48:4664–4672.
3. DeNardo SJ, Warhoe KA, O’Grady LF, Hellstrom I, Hellstrom KE, Mills SL, Macey DJ, Goodnight JE, DeNardo GL. Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibody. Intern Jour of Biological Markers 1991;6: 221–230.
4. Hird V, Maraveyas A, Snook D, Dhokia B, Soutter WP, Meares C, Stewart JS, Mason P, Lambert HE, Epenetos AA. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Brit Jour Canc 1993; 68:403–406.
5. Goldenberg DM. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Semin In Nucl Med 1989;19:332–339.